RiboX Secures FDA IND Clearance for World's First Circular RNA-Based In Vivo CAR-T Therapy

Reports

3

Domains carrying it

2

First reported

9 August 2026

Latest report

9 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 9 August 2026FDA Clears IND for RiboX's RXIM002, Circular RNA CAR-T for ITPclinicaltrialvanguard.com
2. 9 August 2026RiboX Secures FDA IND Clearance for World's First Circular RNA-Based In Vivo CAR-T Therapybiopharmaapac.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• Adicet Bio Announces FDA Clearance of IND Application for ADI-2122 reports · 2 domains · 28 August 2026
• FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune ...11 reports · 11 domains · 1 September 2026
• Orum Therapeutics Receives FDA Clearance For IND Of ORM-1153 In Hematologic Malignancies3 reports · 3 domains · 24 August 2026
• FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer59 reports · 51 domains · 5 September 2026
• BioNTech, Genentech terminate Phase 2 of personalized mRNA cancer vaccine2 reports · 2 domains · 28 August 2026
• FDA Grants Fast Track Designation to BI-1808 Plus Pembrolizumab in Ovarian Cancer2 reports · 2 domains · 7 August 2026

◆ Share

◆ Evidence

3 reports · 2 domains

• RiboX Secures FDA IND Clearance for World's First Circular RNA-Based In Vivo CAR-T Therapybiopharmaapac.com · 9 August 2026
• RiboX's Circular RNA CAR-T IND Clearance Forces the Industry to Rethink Everything It ...clinicaltrialvanguard.com · 9 August 2026
• FDA Clears IND for RiboX's RXIM002, Circular RNA CAR-T for ITPclinicaltrialvanguard.com · 9 August 2026